BARK Inc. (BARK) warrants face NYSE delisting as annual meeting set

Rhea-AI Filing Summary

BARK, Inc. reports that the New York Stock Exchange has started proceedings to delist the company’s warrants and has immediately suspended trading in those warrants because of “abnormally low selling price” levels under NYSE rule 802.01D. Each warrant is exercisable for one share of common stock at an exercise price of $11.50 per share under the ticker “BARK-WS,” and the company does not plan to appeal the NYSE’s determination. The NYSE will apply to the SEC to complete the warrant delisting process.

Trading in BARK’s common stock will continue on the NYSE under the ticker “BARK” and is stated to be unaffected by this action, subject to ongoing compliance with other listing standards. BARK also expects to hold its 2025 Annual Meeting of Stockholders on March 25, 2026, and has set a deadline of December 29, 2025, for stockholders to submit proposals or director nominations under Rule 14a-8, its bylaws, or for inclusion on a universal proxy card.

Positive

• None.

Negative

• NYSE warrant delisting and trading suspension: The NYSE has suspended trading and begun delisting proceedings for BARK’s warrants due to “abnormally low selling price” levels, which can materially reduce warrant liquidity and marketability.

Insights

Equity & derivatives market structure analyst

NYSE will delist BARK warrants, while common stock listing remains.

The NYSE has determined that BARK’s warrants no longer meet listing standards because of “abnormally low selling price” levels under Section 802.01D and has suspended trading. Each warrant represents the right to buy one share of common stock at $11.50 per share, and BARK states it will not appeal, so the delisting process is expected to proceed through an NYSE application to the SEC.

For warrant holders, losing an NYSE listing typically reduces liquidity and may lead to wider bid‑ask spreads or migration to over‑the‑counter trading venues, depending on future arrangements. The company’s common stock continues to trade on the NYSE under “BARK,” and the notice explicitly states that common stock trading is unaffected by the warrant action, provided BARK continues to meet other NYSE listing requirements.

BARK also outlines governance logistics by setting December 29, 2025, as the cutoff for submitting stockholder proposals and director nominations for the expected March 25, 2026 annual meeting. These deadlines frame when governance matters and potential stockholder proposals must be organized for inclusion in the proxy statement or universal proxy card under Rule 14a-8, Rule 14a-19, and the company’s bylaws.

8-K Event Classification

2 items: 3.01, 8.01

2 items

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities

The company received a delisting notice or transferred its listing to a different exchange.

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Understanding 8-K Material Events →

0001819574FALSE00018195742025-12-152025-12-150001819574bark:CommonStockPareValue00001Member2025-12-152025-12-150001819574bark:WarrantsEachWarrantExercisableForOneShareOfCommonStockAtAnExercisePriceOf1150PerShareMember2025-12-152025-12-15

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date Earliest Event Reported):

December 15, 2025

BARK, Inc.

(Exact name of registrant as specified in its charter)

Delaware

001-39691

85-1872418

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(IRS Employer Identification No.)

120 Broadway, Floor 12 New York, NY

10271 (Zip Code)

(Address of Principal Executive Offices)

(855) 501-2275

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.0001

BARK

New York Stock Exchange

Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share

BARK WS

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On December 15, 2025, BARK, Inc. (the “Company”) received notice from the New York Stock Exchange (the “NYSE”) that the NYSE has determined to (i) commence proceedings to delist the Company’s warrants (the “Warrants”) and (ii) immediately suspend trading in the Warrants due to “abnormally low selling price” levels, pursuant to Section 802.01D of the NYSE Listed Company Manual. Each Warrant is presently exercisable for one share of the Company’s common stock at an exercise price per share of $11.50, ticker symbol “BARK-WS.” The Company does not intend to appeal the NYSE determination. To effect the delisting, the NYSE will apply to the Securities and Exchange Commission (the “SEC”) to delist the Warrants upon completion of all applicable procedures.

Trading in the Company’s common stock will continue on the NYSE under the ticker symbol “BARK”, subject to the Company’s continued compliance with the NYSE’s other continued listing requirements, and is unaffected by this action.

Item 8.01 Other Events.

The 2025 Annual Meeting of Stockholders of the Company is expected to take place March 25, 2026 (the “Annual Meeting”). Additional information regarding the Annual Meeting will be provided in the Company’s proxy statement.

Because the date of the Annual Meeting will be held more than 30 days after the anniversary of the Company’s 2024 Annual Meeting of Stockholders, pursuant to Rule 14a-8 (“Rule 14a-8”) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Company is setting a deadline for receipt of Rule 14a-8 stockholder proposals that is a reasonable time before the Company expects to begin to print and send its proxy materials for the Annual Meeting.

Stockholders who wish to have a Rule 14a-8 proposal considered for inclusion in the Company’s proxy statement for the Annual Meeting must ensure that their proposal is received by the Company at the Company’s executive offices at BARK, Inc., 120 Broadway, 12th Floor, New York, New York 10271, on or before December 29, 2025, which the Company has determined is a reasonable time before it expects to begin to print and send its proxy materials for the Annual Meeting. Such stockholder proposals must also comply with the other requirements of Rule 14a-8 in order to be eligible for inclusion in the Company’s proxy statement for the Annual Meeting.

The deadline for stockholder proposals other than pursuant to Rule 14a-8 under the Company’s Amended and Restated Bylaws, including director nominations and other business, is December 29, 2025. Any such proposal or nomination must meet the requirements set forth in the Company’s Amended and Restated Bylaws.

Additionally, in order for stockholders to give timely notice of nominations for directors for inclusion on a universal proxy card for the Annual Meeting, notice must be submitted by December 29, 2025, and must include the information in the notice required by the Company’s Amended and Restated Bylaws and by Rule 14a-19 under the Exchange Act.

All stockholder proposals intended to be considered for inclusion in the Company’s proxy materials for the Annual Meeting must comply with applicable Delaware law, the rules and regulations promulgated by the SEC, and the procedures set forth in the Company’s Amended and Restated Bylaws.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BARK, Inc.
By:			/s/ Allison Koehler
			Name: Allison Koehler
			Title: Chief Legal Officer

Date: December 19, 2025

FAQ

What did BARK Inc. (BARK) announce about its NYSE-listed warrants?

BARK reported that the New York Stock Exchange will commence proceedings to delist its warrants and has immediately suspended trading in those warrants due to “abnormally low selling price” levels under Section 802.01D of the NYSE Listed Company Manual.

Are BARK Inc. (BARK) common shares affected by the NYSE warrant delisting?

The company states that trading in its common stock on the NYSE, under the ticker “BARK”, will continue and is unaffected by the warrant delisting action, as long as BARK remains in compliance with other NYSE continued listing requirements.

What are the terms of BARK Inc.’s delisted warrants?

Each BARK warrant is presently exercisable for one share of BARK common stock at an exercise price of $11.50 per share, and trades, prior to suspension, under the ticker symbol “BARK-WS.”

Will BARK Inc. appeal the NYSE decision to delist its warrants?

No. BARK states that it does not intend to appeal the NYSE’s determination to commence delisting proceedings and suspend trading in the warrants.

When is the expected 2025 Annual Meeting of Stockholders for BARK Inc. (BARK)?

BARK expects its 2025 Annual Meeting of Stockholders to take place on March 25, 2026, with additional details to be provided in its proxy statement.

What is the deadline for BARK Inc. stockholder proposals under Rule 14a-8 for the 2025 Annual Meeting?

Stockholders who wish to have a Rule 14a-8 proposal included in BARK’s proxy statement for the 2025 Annual Meeting must ensure their proposal is received at the company’s executive offices on or before December 29, 2025.

What is the deadline for BARK Inc. director nominations and other non-Rule 14a-8 business?

Under BARK’s Amended and Restated Bylaws, the deadline for director nominations, other business proposals, and universal proxy card nominations for the 2025 Annual Meeting is also December 29, 2025, subject to the information and procedural requirements in the bylaws and Rule 14a-19.